On August 8, the National Cancer Institute (NCI) released its Professional Judgment Budget Proposal for FY 2019. This budget proposal is often referred to as the bypass budget, because it allows the Director of NCI to communicate directly with the White House about budget priorities, rather than going through the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS).
NCI’s proposal includes a $6.38 billion budget for the Institute in FY 2019 – an increase of approximately 12% over NCI’s current FY 2017 budget. The proposed budget also includes $400 million in funding for the Cancer Moonshot Initiative. The bypass budget also outlines key areas of opportunity for cancer research, including prevention, diagnosis, and treatment, as well as reduction of cancer disparities.
ASCO applauds NCI for using this authority to reassert the need for a robust investment in cancer research and support for the Cancer Moonshot. By releasing the bypass budget at this time, NCI can help shape conversations occurring in Congress and the Administration on budget priorities for FY 2018 and FY 2019.
ASCO is calling on Congress to provide $6 billion for NCI in FY 2018. Visit the ACT Network to tell your lawmakers to support federal funding for cancer research in FY 2018 and follow ASCO in Action for updates on cancer policy news.